Parathyroid Allotransplant for Severe Refractory Hypoparathyroidism — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Parathyroid Allotransplant for Severe Refractory Hypoparathyroidism — Stella

Recruiting

Back to Hypoparathyroidism Postprocedural trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Canada

University Health Network, Toronto, Ontario

Key details

Sponsor

Karen Devon

Collaborators

University Health Network, Toronto, University of Toronto

Enrollment target

~5 participants

Started

July 2024

Primary completion

July 2028

Age range

19 Years and older

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov